GenePOC's Investment in SMRT Panels Validated by Medicare Decision
Read the entire Genomeweb interview to learn more on GenePOC's…
GENEPOC ANNOUNCES HEALTH CANADA APPROVAL OF ITS CDIFF TEST
Read the Press Release here.
GenePOC to attend AMP in San Antonio, USA from 31 of October to 3 of November 2018
Come visit our booth #1629 - Discover the power of the PIE and…
GenePOC to attend ID Week in San Francisco, USA from 3 to 7 of October 2018
Come visit our booth #1204 - Discover the power of the PIE and…
GenePOC to attend ASM in Atlanta, USA from 7 to 11 June 2018
GenePOC will participate in the ASM (American Society for Microbiology)…
Practical Patient Care Interview – Infection test for expectant mother
Practical Patient Care talks to Dr Mayra Bermudez Martinez, an…
GenePOC to attend 28th ECCMID in Madrid, Spain from 21 to 24 April
GenePOC will participate in the 28th ECCMID (European Congress…
GenePOC Signs Assay Development Contract for Diagnosis of Respiratory Infections with Novacyt !
Under the terms of the services agreement, Primerdesign will…
2017 IDSA Guidelines State the Role of PCR Testing for C. difficile Diagnosis
Clostridium difficile infection (CDI) is the main cause of infectious…
MedTech Interview - Innovative companies bring new possibilities for molecular diagnostics
GenePOC at the heart of POC testing for infectious diseases…
GenePOC announces the launch of GenePOC™ GBS LB test and its revogene™ instrument in Canada.
GenePOC announces it received clearance from Health Canada for…
GenePOC announces FDA clearance for its CDiff test
GenePOC announces it received 510(k) clearance from the US Food…